Related Experiment Video

Updated: Jul 19, 2026

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
06:39

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats

Published on: October 17, 2018

Increased production of inflammatory cytokines in mild cognitive impairment

Shino Magaki1, Claudius Mueller, Cindy Dickson

  • 1Center for Neurosurgery Research, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.

Experimental Gerontology
|November 7, 2006
PubMed

Insights

Peripheral immune cell cytokine profiles reveal early immune response alterations in mild cognitive impairment (MCI), potentially preceding Alzheimer's disease (AD) onset. These changes in cytokine production by peripheral blood mononuclear cells (PBMCs) may serve as an early biomarker for AD progression.

Area of Science:

  • Immunology
  • Neuroscience
  • Gerontology

Background:

  • Chronic inflammation is implicated in the pathogenesis of Alzheimer's disease (AD) affecting both the central nervous system (CNS) and peripheral systems.
  • Peripheral blood mononuclear cells (PBMCs) offer a window into systemic immune responses relevant to neurodegenerative diseases.

Purpose of the Study:

  • To investigate differential cytokine production in PBMCs from individuals with mild cognitive impairment (MCI) and mild AD.
  • To identify potential immune response alterations that may serve as early biomarkers for Alzheimer's disease progression.

Main Methods:

  • Cytokine arrays were used to screen PBMCs from MCI and mild AD subjects compared to healthy controls.
  • Flow cytometry quantified specific pro-inflammatory (TNF-alpha, IL-6, IL-8) and anti-inflammatory (IL-10) cytokines.
  • PBMCs were stimulated with phytohemagglutinin (PHA) and lipopolysaccharide (LPS) to assess cytokine production patterns.

Main Results:

  • MCI subjects showed significantly increased IL-6, IL-8, and IL-10 levels after 24-hour PHA stimulation compared to controls.
  • Lower TNF-alpha/IL-10, IL-6/IL-10, and IL-8/IL-10 ratios were observed in MCI subjects after 48-hour LPS stimulation.
  • Plasma IL-8 levels did not differ across groups; circulating IL-6 and IL-10 were below detection limits.

Conclusions:

  • Altered cytokine production by PBMCs can be detected early in the MCI stage, preceding clinical diagnosis of AD.
  • These findings suggest a potential role for peripheral immune response modifications in the early pathogenesis of Alzheimer's disease.
  • PBMC cytokine profiles may represent a valuable, non-invasive biomarker for early detection and monitoring of AD-related changes.

More Related Videos

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model08:22

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model

Published on: June 20, 2025

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...